Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Puma Biotechnology 

10940 Wilshire Blvd, Suite 600

Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


 Company News
Puma Biotechnology (PBYI) Announces Positive Interim PB272 (Neratinib) Phase 2 Data At 2014 CTRC-American Association for Cancer Research San Antonio Breast Cancer Symposium 12/12/2014 8:12:35 AM
Puma Biotechnology (PBYI) Updates Timeline For Filing New Drug Application 12/3/2014 8:57:53 AM
Puma Biotechnology (PBYI) Sinks On Breast Cancer Drug NDA Delay 12/3/2014 6:48:31 AM
Puma Biotechnology (PBYI) Announces Positive Top Line Results From PB272 Phase 2 Trial In HER2 Positive Metastatic Breast Cancer (Nefertt Trial) 11/14/2014 6:27:16 AM
Puma Biotechnology (PBYI)'s Cancer Drug Neratinib Fails Mid-Stage Study 11/14/2014 6:26:27 AM
Puma Biotechnology (PBYI) To Present At Stifel 2014 Healthcare Conference 11/12/2014 10:30:28 AM
Puma Biotechnology (PBYI) Reports Third Quarter 2014 Financial Results 11/11/2014 9:14:27 AM
Puma Biotechnology (PBYI) Announces Positive Initial Results From PB272 Phase II Trial In HER2 Mutated Non-Small Cell Lung Cancer 9/29/2014 11:40:22 AM
Puma Biotechnology (PBYI) Announces Late-Breaking Oral Presentation On Neratinib In NSCLC With HER2 Mutations At ESMO 2014 9/3/2014 8:58:09 AM
Puma Biotechnology (PBYI) Reports Second Quarter 2014 Financial Results 8/12/2014 8:39:42 AM